Hallucinogenic N-methylated indolealkylamines in the cerebrospinal fluid of psychiatric and control populations
- PMID: 272218
- DOI: 10.1192/bjp.132.2.139
Hallucinogenic N-methylated indolealkylamines in the cerebrospinal fluid of psychiatric and control populations
Abstract
The incidence and quantities of dimethyltryptamine and O-methylbufotenine were studied in the cerebrospinal fluid of patients suffering acute schizophrenic illnesses and in surgical and neurological control groups. Some schizophrenic patients have higher levels of both amines than do controls, though the differences in distribution did not reach statistical significance in the sample studied. The gas-chromatographic technique used is sensitive at the low picogram level.
Similar articles
-
Identification of dimethyltryptamine and O-methylbufotenin in human cerebrospinal fluid by combined gas chromatography/mass spectrometry.Biol Psychiatry. 1979 Jun;14(3):549-56. Biol Psychiatry. 1979. PMID: 289421 No abstract available.
-
A test of the transmethylation hypothesis in acute schizophrenic patients.Am J Psychiatry. 1975 Oct;132(10):1067-71. doi: 10.1176/ajp.132.10.1067. Am J Psychiatry. 1975. PMID: 1058643
-
Mass fragmentographic quantification of urinary N,N-dimethyltryptamine and bufotenine.J Chromatogr. 1979 Apr 11;162(4):579-84. doi: 10.1016/s0378-4347(00)81837-x. J Chromatogr. 1979. PMID: 118980 No abstract available.
-
A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.Drug Test Anal. 2012 Jul-Aug;4(7-8):617-35. doi: 10.1002/dta.422. Epub 2012 Feb 28. Drug Test Anal. 2012. PMID: 22371425 Review.
-
Observations on the metabolism of the psychotomimetic indolealkylamines: implications for future clinical studies.Biol Psychiatry. 1990 Nov 15;28(10):841-8. doi: 10.1016/0006-3223(90)90566-k. Biol Psychiatry. 1990. PMID: 2268688 Review.
Cited by
-
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.J Neural Transm (Vienna). 2009 Dec;116(12):1591-9. doi: 10.1007/s00702-009-0308-8. Epub 2009 Sep 12. J Neural Transm (Vienna). 2009. PMID: 19756361
-
Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamine.Biochemistry. 2014 May 13;53(18):2956-65. doi: 10.1021/bi500175p. Epub 2014 Apr 28. Biochemistry. 2014. PMID: 24730580 Free PMC article.
-
A narrative synthesis of research with 5-MeO-DMT.J Psychopharmacol. 2022 Mar;36(3):273-294. doi: 10.1177/02698811211050543. Epub 2021 Oct 19. J Psychopharmacol. 2022. PMID: 34666554 Free PMC article. Review.
-
Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.Psychopharmacology (Berl). 1979 Apr 25;62(3):207-10. doi: 10.1007/BF00431949. Psychopharmacology (Berl). 1979. PMID: 111285
-
The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).J Neurochem. 2022 Jul;162(1):128-146. doi: 10.1111/jnc.15587. Epub 2022 Mar 8. J Neurochem. 2022. PMID: 35149998 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources